Citigroup
CASI

Citigroup’s CASI Pharmaceuticals CASI Stock Holding History

Citigroup’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-19
Closed -$22 – 6107
2025
Q2 		$22 Buy
+19
New +$35 ﹤0.01% 5567
2022
Q2 		– Sell
-7,312
Closed -$59K – 6263
2022
Q1 		$59K Buy
+7,312
New +$57.4K ﹤0.01% 4651
2021
Q2 		– Sell
-437
Closed -$10K – 6142
2021
Q1 		$10K Sell
437
-741
-63% -$20.8K ﹤0.01% 5627
2020
Q4 		$35K Buy
1,178
+860
+270% +$18.7K ﹤0.01% 6281
2020
Q3 		$5K Sell
318
-421
-57% -$7.93K ﹤0.01% 6981
2020
Q2 		$18K Sell
739
-628
-46% -$13.6K ﹤0.01% 6685
2020
Q1 		$28K Buy
1,367
+356
+35% +$8.49K ﹤0.01% 6445
2019
Q4 		$31K Buy
1,011
+322
+47% +$10.4K ﹤0.01% 6683
2019
Q3 		$23K Sell
689
-712
-51% -$22.9K ﹤0.01% 6646
2019
Q2 		$45K Buy
1,401
+60
+4% +$1.92K ﹤0.01% 6568
2019
Q1 		$38K Buy
1,341
+119
+10% +$4.15K ﹤0.01% 6550
2018
Q4 		$50K Sell
1,222
-148
-11% -$5.61K ﹤0.01% 6241
2018
Q3 		$64K Buy
+1,370
New +$95.6K ﹤0.01% 6304
2015
Q4 		– Sell
-1,150
Closed -$12K – 7574
2015
Q3 		$12K Hold
1,150
– – ﹤0.01% 6324
2015
Q2 		$21K Hold
1,150
– – ﹤0.01% 6068
2015
Q1 		$17K Hold
1,150
– – ﹤0.01% 6170
2014
Q4 		$15K Hold
1,150
– – ﹤0.01% 6329
2014
Q3 		$21K Buy
+1,150
New +$20.5K ﹤0.01% 5876
2014
Q2 		– Sell
-1,150
Closed -$21K – 7122
2014
Q1 		$21K Hold
1,150
– – ﹤0.01% 5986
2013
Q4 		$20K Hold
1,150
– – ﹤0.01% 6168
2013
Q3 		$20K Sell
1,150
-1
-0.1% -$19 ﹤0.01% 5906
2013
Q2 		$23K Buy
+1,151
New +$22.3K ﹤0.01% 5760

Other funds holding CASI

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

Citigroup's CASI Position: Q3 2025 in Review

Citigroup sold out of CASI Pharmaceuticals (CASI) in Q3 2025, closing a stake of 19 shares — an estimated $22 sold.

Citigroup first reported a position in CASI in Q2 2013 and held it in 22 quarters. The position peaked at $64K in Q3 2018. 22 funds tracked by Wall St. Rank hold CASI as of Q3 2025.

  • Citigroup reported no remaining CASI Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Citigroup sold 19 CASI Pharmaceuticals shares in Q3 2025, an estimated $22.
  • Citigroup first reported a position in CASI Pharmaceuticals in Q2 2013 and held it in 22 quarters.
  • Citigroup's CASI Pharmaceuticals position peaked at $64K in Q3 2018.
  • 22 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q3 2025.

Based on Citigroup's 13F filing for Q3 2025, filed 10 Nov 2025.